A new AI tool identifies generic drugs with anticancer potential
Researchers use machine learning to identify generic drugs that are promising candidates for affordable and accessible cancer treatments.
prostate cancer
Heavy lifting with HULLK
APIS, University of Virginia hope to leverage HULLK lncRNA as a prostate cancer biomarker
